Silo Pharma reduces authorized shares to 100M, adjourns annual meeting for Nevada reincorporation

Silo Pharma, Inc.

Shareholders approved decrease of authorized common stock from 500M to 100M; Certificate of Amendment filed Dec 4, 2023.
Annual meeting adjourned solely for Proposal 3 (reincorporation from Delaware to Nevada); other proposals approved.
Reconvened meeting set for Dec 11, 2023 at 11am ET in Sarasota, FL; record date Oct 12, 2023 unchanged.
Proxies already submitted will be voted on reincorporation; stockholders need not vote again.

item 5.03 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Silo Pharma, Inc.: Decreased authorized shares of common stock from 500,000,000 to 100,000,000 (effective 2023-12-04).

Change: charter amendment
Effective: 2023-12-04

Exact text from the filing

On December 4, 2023, the Company filed a Certificate of Amendment (the “Amendment”) to its Certificate of Incorporation with the Delaware Secretary of State to decrease its authorized shares of common stock from 500,000,000 shares to 100,000,000 shares.

View on SEC.gov

13 governance changes filed in the last 30 days. Browse all governance changes →

Silo Pharma, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-23-093122

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.